Electronic Patient-reported Outcome Monitoring in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

July 6, 2020

Study Completion Date

July 6, 2020

Conditions
Aplastic AnemiaParoxysmal Nocturnal Hemoglobinuria
Interventions
OTHER

symptom questionnaire

"A weekly filled in symptom questionnaire for reported symptoms of AA and/or PNH (yes/no, grade, date). Grading according to current grading systems (Common Terminology Criteria for Adverse Events,CTCAE).~Data collection and processing via the ePRO application by Kaiku Health Ltd"

OTHER

recording of vital signs

Record function for vital parameters (blood pressure, temperature and pulse); Data collection and processing via the ePRO application by Kaiku Health Ltd

OTHER

European Organisation for Research and Treatment of Cancer (EORTC) quality of life questionnaire (QLQ)-C30 questionnaire

The EORTC QLQ-C30 incorporates nine multi-item scales: five functional scales (Physical, Role, Cognitive, Emotional and Social Functioning); three symptom scales (Fatigue, Pain and Nausea/Vomiting); and a Global Health Status/QoL scale. Six single item scales are also included (Dyspnoea, Insomnia, Appetite Loss, Constipation, Diarrhoea and Financial Difficulties). All of the scales range in score from 0 to 100. A high score for a functional scale represents a high/healthy level of functioning whereas a high score for a symptom scale or item represents a high level of symptomatology or problems.

OTHER

interview

Interview with the patients and responsible medical team by phone or during hospital visit about functional problems regarding the application (duration: 15-30 min) to avoid incorrect use of the application, at week 3 and month 3 and month 6

Trial Locations (1)

4031

Division of Hematology, University Hospital Basel, Basel

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ProPatient foundation of the University Hospital Basel

UNKNOWN

collaborator

Novartis

INDUSTRY

lead

University Hospital, Basel, Switzerland

OTHER